PHSRX Mutual Fund

NAV$55.73

Fund Essentials - as of Feb 28, 2026

Net Assets
-
Expense Ratio
1.29%
Dividend Yield (Current)
0.19%
Holdings
119
Inception Date
Jan 21, 2003
Fund Family
Putnam Investments
Investment Style
••••••••••
Asset Class
••••••••••
Legal Structure
••••••••••
Dividend Frequency
Annually

Performance

YTD-1.77%
1 Year+17.15%
3 Year+7.91%
5 Year+7.56%
10 Year+9.60%

Asset Allocation

Stocks: 98.25%
Bonds: 0.15%
Other: 1.60%

Top Holdings

View All →
TickerNameWeight
LLYEli Lilly & Co11.34%
JNJJohnson & Johnson8.91%
ABBVAbbvie Inc5.94%
NOVN:SMNovartis Ag Reg5.53%
MRKMerck & Company Inc5.33%
Top 10 Concentration: 57.52%Report Date: Feb 28, 2026
Download all 119 holdings for PHSRX
CSV export with sector, industry & share changes
Get CSV

Dividend Summary

View Details →
Dividend Yield (Current)
0.19%
Frequency
Annually

Peer Comparison

Benchmark
••••••••••
Outperforming by ••••%
Ranked #••• of •,••• funds
This Mutual Fund
+••.••%
Peer Avg
+••.••%
Premium Feature
Sign in to unlock peer comparison, category rankings and more

PHSRX Mutual Fund Overview

PHSRX Mutual Fund (Putnam Global Health Care Fund Class R) is managed by Putnam Investments. PHSRX expense ratio is 1.29%, holding 119 positions across sectors including Health Care, Unknown, Other. Inception date: 2003-01-21.

PHSRX performance shows a YTD return of -1.77%. The 1-year return is 17.15% and the 5-year return is 7.56%. PHSRX dividend yield stands at 0.19%, paid annually.

PHSRX top holdings include Eli Lilly & Co (11.3%), Johnson & Johnson (8.9%), Abbvie Inc (5.9%), Novartis Ag Reg (5.5%), Merck & Company Inc (5.3%). View all PHSRX holdings, sector breakdown, or dividend history.

PHSRX can be compared against other funds using the overlap calculator or side-by-side comparison tool. PHSRX alternatives are available via the screener, along with tax-loss harvesting opportunities.